The Bundibugyo strain of Ebola, with a fatality rate up to 50 percent, currently lacks an approved vaccine. Developing a vaccine for this variant presents significant challenges.

The Bundibugyo strain of Ebola has a fatality rate of up to 50 percent and no approved vaccine as yet.